Erik Änggård
Impact in
- Biochemistry top 0.05%
- Eicosanoids and Hypertension Pharmacology
- Antioxidant Activity and Oxidative Stress
- Pharmacology top 0.1%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
- Biochemistry 52
- Eicosanoids and Hypertension Pharmacology 52
- Antioxidant Activity and Oxidative Stress 24
- Pharmacology 54
- Inflammatory mediators and NSAID effects 43
- Co-authors
- John R. VaneBengt SamuelssonCarin LarssonRegina M. BottingFranklin H. EpsteinMartin CarrierN.K. GopaulJaffar Nourooz‐Zadeh
- Journals
- European Journal of Pharmacology (11 papers)British Journal of Pharmacology (9 papers)Journal of Cardiovascular Pharmacology (8 papers)Biochemical and Biophysical Research Communications (7 papers)Journal of Neurochemistry (6 papers)
- Partner nations
- United KingdomSwedenUnited States
In The Last Decade
Erik Änggård
186 papers receiving 11.8k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Biochemistry 2.2k
- Pharmacology 2.6k
- Biochemistry 884
- Physiology 3.7k
- Cardiology and Cardiovascular Medicine 2.2k
Countries citing papers authored by Erik Änggård
This map shows the geographic impact of Erik Änggård's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Änggård with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Änggård more than expected).
Fields of papers citing papers by Erik Änggård
This network shows the impact of papers produced by Erik Änggård. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Änggård. The network helps show where Erik Änggård may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Änggård, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 114 | |
| 2 | 2000 | 73 | |
| 3 | 2000 | 49 | |
| 4 | 1999 | 73 | |
| 5 | 1997 | 9 | |
| 6 | 1996 | 18 | |
| 7 | 1996 | 21 | |
| 8 | 1995 | 22 | |
| 9 | Nitric oxide: mediator, murderer, and medicine Hit paper breakdown → | 1994 | 678 |
| 10 | 1993 | 8 | |
| 11 | 1993 | 25 | |
| 12 | 1992 | 19 | |
| 13 | 1992 | 94 | |
| 14 | 1991 | 20 | |
| 15 | 1989 | 131 | |
| 16 | 1989 | 26 | |
| 17 | Chronic ethanol exposure enhances essential fatty acid deficiency in rats. | 1983 | 11 |
| 18 | Amphetamine, psychotogen, and marihuana dependence | 1977 | 1 |
| 19 | Affinity chromatography of 15-hydroxyprostaglandin dehydrogenases from swine kidney. | 1976 | 3 |
| 20 | Substrate specificity and inhibition of 15 hydroxy prostaglandin dehydrogenase | 1969 | 3 |
About Erik Änggård
Erik Änggård is a scholar working on Biochemistry, Biochemistry, Pharmacology, Physiology and Toxicology, having authored 187 papers that have together received 12.7k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (56 papers), Eicosanoids and Hypertension Pharmacology (52 papers), Inflammatory mediators and NSAID effects (43 papers), Antioxidant Activity and Oxidative Stress (24 papers), Peroxisome Proliferator-Activated Receptors (14 papers), Analytical Chemistry and Chromatography (11 papers), Free Radicals and Antioxidants (10 papers) and Alcohol Consumption and Health Effects (10 papers). The work is most often cited by research in Biochemistry (2.2k citations), Pharmacology (2.6k citations), Biochemistry (884 citations), Physiology (3.7k citations) and Cardiology and Cardiovascular Medicine (2.2k citations). Erik Änggård has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include John R. Vane, Bengt Samuelsson, Carin Larsson, Regina M. Botting, Franklin H. Epstein, Martin Carrier, N.K. Gopaul, Jaffar Nourooz‐Zadeh, Birgitta Sjöquist and A. Wright. Their work appears in journals such as European Journal of Pharmacology, British Journal of Pharmacology, Journal of Cardiovascular Pharmacology, Biochemical and Biophysical Research Communications and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.